UPDATE : Wednesday, August 21, 2019
상단여백
Kolmar apologizes for playing controversial YouTube clip
Kolmar Korea, the nation’s largest manufacturer of cosmetic products which ...
by Lee Han-soo  |  2019-08-09 16:48
라인
Diabetes drug Jardiance pressures heart failure treatment Entresto
Novartis’ new heart failure treatment Entresto (ingredient: sacubitril/vals...
by Kim Yun-mi  |  2019-08-09 15:44
라인
AstraZeneca’s Lynparza show positive results for prostate cancer in P3 trial
AstraZeneca and MSD announced positive results from their phase 3 PROfound ...
by Lee Han-soo  |  2019-08-08 16:48
라인
‘CPhI Korea thriving on local firms’ zeal for drug export’
Korea Pharmaceutical Traders Association (KPTA) said it would open a large-...
by Jeong Sae-im  |  2019-08-08 14:54
라인
Hanmi’s US partner unveils P3 data on oral anticancer drug
Athenex, Hanmi’s U.S. partner, presented the topline data showing that Orax...
by Lee Han-soo  |  2019-08-08 14:53
라인
'Daewoong risk' could put a damper on AbbVie-Allergan mega-merger
Daewoong Pharmaceutical's launch of Jeuveau, its botulinum toxin (BTX) ...
by Lee Han-soo  |  2019-08-07 16:22
라인
Lilly’s anticancer combo drug nears getting insurance benefit
Eli Lilly said its anticancer drug Verzenio showed an improvement in overal...
by Kim Yun-mi  |  2019-08-07 15:44
라인
Lilly reports improved survival for Verzenio in P3 trial
Eli Lilly Korea said that Verzenio (Ingredient: Abemaciclib) demonstrated a...
by Lee Han-soo  |  2019-08-07 12:06
라인
ISU Abxis to unveil p1 results for anticancer treatment in Europe
ISU Abxis will present its phase 1 clinical trial data for ISU104, an Erb-B...
by Lee Han-soo  |  2019-08-07 12:03
라인
Crystal Genomics signs accord with CRO firm
Crystal Genomics said that it has signed an agreement with PRA Health Scien...
by Lee Han-soo  |  2019-08-06 17:20
라인
Japanese firms fear boycott may hurt prescription drug sales
Korean offshoots of Japanese pharmaceutical companies are worrying that the...
by Kim Yun-mi  |  2019-08-06 15:44
라인
Sillajen cites salvation therapy as reason for trial suspension advice
Sillajen said that it believes that the Independent Data Monitoring Committ...
by Lee Han-soo  |  2019-08-06 15:43
라인
Market value of biopharmaceuticals drops ₩10 trillion on 'Black Monday'
Biopharmaceutical shares in the nation’s secondary bourse had their worst d...
by Lee Han-soo  |  2019-08-06 13:50
라인
Crystal Genomics confirms efficacy of inflammatory bowel disease treatment
Crystal Genomics said that it has confirmed the efficacy of CG-598, an infl...
by Lee Han-soo  |  2019-08-05 17:02
라인
Boycott of Japanese drug intensifies as Seoul-Tokyo relations worsen
With Japan deciding to remove South Korea from the list of trusted trading ...
by Lee Han-soo  |  2019-08-05 16:01
라인
Amgen’s lipid-lowering Repatha beats Sanofi’s Praluent in Q2 sales
Amgen won the battle against Sanofi in sales of cholesterol-lowering PCSK9 ...
by Kim Yun-mi  |  2019-08-05 15:37
라인
Helixmith unveils results for neuromuscular disease treatment
Helixmith has published a study that confirmed the efficacy of AV6-H’s, a g...
by Lee Han-soo  |  2019-08-02 17:52
라인
‘MSD Korea playing tricks to maintain monitoring on salespersons’
MSD Korea’s labor and management are again in dispute over the so-called “s...
by Kim Yun-mi  |  2019-08-02 15:48
라인
Conflict erupts between employees of Takeda, Shire during merger
Takeda Pharmaceutical Korea’s labor union said Takeda employees faced unfai...
by Kim Yun-mi  |  2019-08-02 14:23
라인
Sillajen likely to scrap global P3 trials for Pexa-Vec
Sillajen is in danger of aborting its phase 3 clinical trial for Pexa-Vec (...
by Lee Han-soo  |  2019-08-02 10:29
여백
여백
여백
Back to Top